ARCHIVES

Interim Analysis of Phase III Data Preferable For Accelerated Approval, FDA’s Pazdur Says

This article is from The Cancer Letter archive.

Vol. 28 No. 32 | September 6, 2002

Download PDF Visit The Full Archive

Related Articles

FDA Approved 88% Of Cancer Applications Since Oncology Office Opened In 2005.

July 3, 2008

Roche Markets CMV Test in Europe

April 29, 2011

Organ Systems Extension to CNS, Aerodigestive Tract Considered

July 26, 1985

USPSTF Recommends Hepatitis C Screening For Baby Boomers

June 26, 2013

Taking Tykerb With Food Increased Drug Concentration; Paper Urges More Research

July 27, 2007

White House appoints NCI Director Andrew von Eschenbach acting FDA commissioner after Lester Crawford resigns.

September 30, 2005